Cargando…
Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway
Hepatocellular carcinoma (HCC) is one of the common malignances in the world and has high mortality in part due to development of acquired drug resistance. Therefore, it is urgent to investigate the molecular mechanism of drug resistance in HCC. To explore the underlying mechanism of drug resistance...
Autores principales: | Wu, Qiong, Wang, Rui, Yang, Qingling, Hou, Xin, Chen, Sulian, Hou, Yueyue, Chen, Changjie, Yang, Yan, Miele, Lucio, Sarkar, Fazlul H, Chen, Yuqing, Wang, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875765/ https://www.ncbi.nlm.nih.gov/pubmed/24158561 |
Ejemplares similares
-
The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells
por: Wang, Rui, et al.
Publicado: (2015) -
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1α Accumulation via Increased Production of Reactive Oxygen Species
por: Ma, Jia, et al.
Publicado: (2013) -
MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells
por: Yang, Qingling, et al.
Publicado: (2014) -
The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1
por: Wu, Haihua, et al.
Publicado: (2018) -
NT21MP negatively regulates paclitaxel-resistant cells by targeting miR-155-3p and miR-155-5p via the CXCR4 pathway in breast cancer
por: Wang, Yueyue, et al.
Publicado: (2018)